PRPO
Precipio, Inc. Common Stock
stockNASDAQ
precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. our goal is to assist oncologists in providing the best care for their patients. at the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the yale school of medicine. at precipio, our customers and their patients benefit from the most accurate, expert diagnosis. we provide our customers exclusive access to some of the most innovative tests in the field of molecular diagnostics, developed through cutting edge research, and the ongoing pursuit and refinement of the science of personalized medicine.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 18.62 | 2026-11-06 | +19.95% | 6.229 |
| 1M | 22.59 | 2026-10-13 | -1.13% | 2.669 |
| 3M | 23.21 | 2026-08-13 | -3.77% | 1.880 |
| 6M | 28.70 | 2026-05-13 | -22.18% | 1.233 |
| 1Y | 19.52 | 2025-11-13 | +14.42% | 0.819 |
| 2Y | 6.35 | 2024-11-13 | +251.73% | — |
| 5Y | 46.40 | 2021-11-12 | -51.86% | 0.248 |
Precipio, Inc. Common Stock (NASDAQ:PRPO) stock price today is $22.34, and today's volume is 13,523. PRPO is down 3.935% today. The 30 day average volume is 34,415. PRPO market cap is $40.05M with 1.79M shares outstanding.